Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DE CRUSNES : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE CRUSNES is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CRUSNES (54680), this company of category PME shows in 2023 a net income positive of 159 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE CRUSNES (SIREN 822460408)
Indicator 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 158 732 € 267 097 € 208 468 € 132 847 € 157 496 € 141 274 € 41 864 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, SELARL PHARMACIE DE CRUSNES generates positive net income of 159 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 42 k€ -> 159 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

158 732 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 40%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

40.075%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.629%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.2%

Solvency indicators evolution
SELARL PHARMACIE DE CRUSNES

Sector positioning

Debt ratio
40.08 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Good -12 pts over 3 years

In 2023, the debt ratio of SELARL PHARMACIE DE CRUSNES (40.08) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
65.63% 2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Good +15 pts over 3 years

In 2023, the financial autonomy of SELARL PHARMACIE DE CRUSNES (65.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 517.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

517.741

Liquidity indicators evolution
SELARL PHARMACIE DE CRUSNES

Sector positioning

Liquidity ratio
517.74 2023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Excellent

In 2023, the liquidity ratio of SELARL PHARMACIE DE CRUSNES (517.74) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELARL PHARMACIE DE CRUSNES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELARL PHARMACIE DE CRUSNES is estimated at 1 872 954 € (range 1 139 033€ - 2 632 953€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
1139k€ 1872k€ 2632k€
1 872 954 € Range: 1 139 033€ - 2 632 953€
NAF 5 année 2023

Valuation method used

Net Income Multiple
158 732 € × 11.8x = 1 872 954 €
Range: 1 139 033€ - 2 632 954€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE CRUSNES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DE CRUSNES

What is the revenue of SELARL PHARMACIE DE CRUSNES ?

The revenue of SELARL PHARMACIE DE CRUSNES is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DE CRUSNES profitable?

Yes, SELARL PHARMACIE DE CRUSNES generated a net profit of 159 k€ in 2023.

Where is the headquarters of SELARL PHARMACIE DE CRUSNES ?

The headquarters of SELARL PHARMACIE DE CRUSNES is located in CRUSNES (54680), in the department Meurthe-et-Moselle.

Where to find the tax return of SELARL PHARMACIE DE CRUSNES ?

The tax return of SELARL PHARMACIE DE CRUSNES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE CRUSNES operate?

SELARL PHARMACIE DE CRUSNES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.